BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 1311634)

  • 1. Molecular characterization of areas with low grade tumor or satellitosis in human malignant astrocytomas.
    Leenstra S; Troost D; Westerveld A; Bosch DA; Hulsebos TJ
    Cancer Res; 1992 Mar; 52(6):1568-72. PubMed ID: 1311634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p53 mutation and loss of heterozygosity on chromosomes 17 and 10 during human astrocytoma progression.
    Fults D; Brockmeyer D; Tullous MW; Pedone CA; Cawthon RM
    Cancer Res; 1992 Feb; 52(3):674-9. PubMed ID: 1346255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loci associated with malignant progression in astrocytomas: a candidate on chromosome 19q.
    von Deimling A; Bender B; Jahnke R; Waha A; Kraus J; Albrecht S; Wellenreuther R; Fassbender F; Nagel J; Menon AG
    Cancer Res; 1994 Mar; 54(6):1397-401. PubMed ID: 8137236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic alterations associated with glioma progression.
    Kleihues P; Lübbe J; Watanabe K; von Ammon K; Ohgaki H
    Verh Dtsch Ges Pathol; 1994; 78():43-7. PubMed ID: 7534015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathways leading to glioblastoma multiforme: a molecular analysis of genetic alterations in 65 astrocytic tumors.
    Lang FF; Miller DC; Koslow M; Newcomb EW
    J Neurosurg; 1994 Sep; 81(3):427-36. PubMed ID: 8057151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular pathogenesis of pediatric astrocytic tumors.
    Nakamura M; Shimada K; Ishida E; Higuchi T; Nakase H; Sakaki T; Konishi N
    Neuro Oncol; 2007 Apr; 9(2):113-23. PubMed ID: 17327574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allelotype of human malignant astrocytoma.
    Fults D; Pedone CA; Thomas GA; White R
    Cancer Res; 1990 Sep; 50(18):5784-9. PubMed ID: 1975510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of heterozygosity for loci on chromosome 17p in human malignant astrocytoma.
    Fults D; Tippets RH; Thomas GA; Nakamura Y; White R
    Cancer Res; 1989 Dec; 49(23):6572-7. PubMed ID: 2573417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular analysis of genomic abnormalities in human gliomas.
    Bello MJ; de Campos JM; Kusak ME; Vaquero J; Sarasa JL; Pestaña A; Rey JA
    Cancer Genet Cytogenet; 1994 Apr; 73(2):122-9. PubMed ID: 8174086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p53 mutation, EGFR gene amplification and loss of heterozygosity on chromosome 10, 17 p in human gliomas.
    Jin W; Xu X; Yang T; Hua Z
    Chin Med J (Engl); 2000 Jul; 113(7):662-6. PubMed ID: 11776043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Somatic mutations of PTEN in glioblastoma multiforme.
    Wang SI; Puc J; Li J; Bruce JN; Cairns P; Sidransky D; Parsons R
    Cancer Res; 1997 Oct; 57(19):4183-6. PubMed ID: 9331071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a human homolog of the Drosophila neuralized gene within the 10q25.1 malignant astrocytoma deletion region.
    Nakamura H; Yoshida M; Tsuiki H; Ito K; Ueno M; Nakao M; Oka K; Tada M; Kochi M; Kuratsu J; Ushio Y; Saya H
    Oncogene; 1998 Feb; 16(8):1009-19. PubMed ID: 9519875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of heterozygosity of a locus on 17p13.3, independent of p53, is associated with higher grades of astrocytic tumours.
    Chattopadhyay P; Rathore A; Mathur M; Sarkar C; Mahapatra AK; Sinha S
    Oncogene; 1997 Aug; 15(7):871-4. PubMed ID: 9266974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The retinoblastoma gene is involved in malignant progression of astrocytomas.
    Henson JW; Schnitker BL; Correa KM; von Deimling A; Fassbender F; Xu HJ; Benedict WF; Yandell DW; Louis DN
    Ann Neurol; 1994 Nov; 36(5):714-21. PubMed ID: 7979217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Instability of microsatellites in human gliomas.
    Dams E; Van de Kelft EJ; Martin JJ; Verlooy J; Willems PJ
    Cancer Res; 1995 Apr; 55(7):1547-9. PubMed ID: 7882363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The putative tumor suppressor gene FHIT at 3p14.2 is rarely affected by loss of heterozygosity in primary human brain tumors.
    Frank S; Müller J; Plaschke J; Hahn M; Hampl J; Hampl M; Pistorius S; Schackert G; Schackert HK
    Cancer Res; 1997 Jul; 57(13):2638-41. PubMed ID: 9205070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.
    Barbashina V; Salazar P; Holland EC; Rosenblum MK; Ladanyi M
    Clin Cancer Res; 2005 Feb; 11(3):1119-28. PubMed ID: 15709179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for a tumor suppressor gene on chromosome 19q associated with human astrocytomas, oligodendrogliomas, and mixed gliomas.
    von Deimling A; Louis DN; von Ammon K; Petersen I; Wiestler OD; Seizinger BR
    Cancer Res; 1992 Aug; 52(15):4277-9. PubMed ID: 1353411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA hypermethylation is associated with 17p allelic loss in neural tumors.
    Makos M; Nelkin BD; Chazin VR; Cavenee WK; Brodeur GM; Baylin SB
    Cancer Res; 1993 Jun; 53(12):2715-8. PubMed ID: 8389241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chromosome 10 and 17 deletions and p53 gene mutations in Thai patients with astrocytomas.
    Put-Ti-Noi S; Petmitr S; Chanyavanich V; Sangruji T; Theerapuncharoen V; Hayashi K; Thangnipon W
    Oncol Rep; 2004 Jan; 11(1):207-11. PubMed ID: 14654927
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.